| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/10/2009 | US7501399 Immunoeffector compounds |
| 03/10/2009 | US7501134 Biodegradable, formed without the use of surfactant; diagnosis, therapy vaccines, and/or in raising immune response; poly(D,L-lactide-co-glycolide) and antigens such as HIV antigens, meningitis B antigens, streptococcus antigens, hepatitis B virus antigens, hepatitis C virus antigens, pertussis antigens |
| 03/10/2009 | US7501125 Vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent |
| 03/10/2009 | US7501122 Treating ErbB2-expressing breast cancer in a human by administering huMAb4D5-8 antibody and humanized 2C4 antibody variant 574 |
| 03/10/2009 | US7501120 Humanized antibody binds to CD19 chemically coupled to a maytansinoid that is N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine or N2'-deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)-maytansine; sodium citrate, acetate, or succinate buffer; polysorbate, sodium chloride and water; antitumor agents |
| 03/10/2009 | US7500444 Actuation indicator for a dispensing device |
| 03/10/2009 | CA2449856C Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells |
| 03/10/2009 | CA2430288C A composition improved in the solubility or oral absorbability |
| 03/10/2009 | CA2363071C Injection molding process for neutral and acid-group containing (meth)acrylate copolymers |
| 03/10/2009 | CA2301057C A method of administering liposomal encapsulated taxane |
| 03/06/2009 | CA2639419A1 Dendritic salt therapeutic agent delivery system |
| 03/05/2009 | WO2009029935A1 Drug delivery vehicle that mimics viral properties |
| 03/05/2009 | WO2009029801A2 Selective cytopheresis devices and related methods thereof |
| 03/05/2009 | WO2009028965A1 Surgical hydrogel |
| 03/05/2009 | WO2009028900A2 Oral administration drug comprising clopidogrel besylate |
| 03/05/2009 | WO2009028764A1 Thermo-reversible coacervate combination gels for protein delivery |
| 03/05/2009 | WO2009028674A1 Latanoprost-containing aqueous pharmaceutical composition |
| 03/05/2009 | WO2009028650A1 Emulsion-type external preparation, and method for production thereof |
| 03/05/2009 | WO2009028649A1 Method for reduction in volume of solid preparation having high amino acid content |
| 03/05/2009 | WO2009028598A1 Sustained release preparation and process for production thereof |
| 03/05/2009 | WO2009028583A1 Process for producing coated preparation |
| 03/05/2009 | WO2009028495A1 Agent for fungal dermatitis |
| 03/05/2009 | WO2009028487A1 Process for production of tablets containing both crystalline cellulose and granules |
| 03/05/2009 | WO2009027844A2 Crf conjugates with extended half-lives |
| 03/05/2009 | WO2009027706A2 Radiolabeled monomeric and multimeric cyclic oligopeptides binding to the cxcr4 receptor for cancer imaging and treatment |
| 03/05/2009 | WO2009027697A2 Non-aqueous pharmaceutical compositions |
| 03/05/2009 | WO2009027690A1 Diagnostic agent |
| 03/05/2009 | WO2009027688A1 Influenza antigen delivery vectors and constructs |
| 03/05/2009 | WO2009027679A1 Process for the preparation of guanidino substituted bi-and polyphenyls that are suitable as small molecule carriers |
| 03/05/2009 | WO2009027506A2 Local topical administration formulations containing fipronil |
| 03/05/2009 | WO2009027452A2 Radiopharmaceutical composition |
| 03/05/2009 | WO2009027437A1 Liquid formulation of g-csf conjugate |
| 03/05/2009 | WO2009027076A1 Liquid formulation of g-csf |
| 03/05/2009 | WO2009026729A1 Amino acid pairing-based self assembling peptides and methods |
| 03/05/2009 | WO2009026723A1 Antigenic compositions and use of same in the targeted delivery of nucleic acids |
| 03/05/2009 | WO2009026692A1 An anti-cancer cytotoxic monoclonal antibody |
| 03/05/2009 | WO2009012303A9 Therapeutic stable nanoparticles |
| 03/05/2009 | WO2009010305A3 Tablettable formulations of lipophilic health ingredients |
| 03/05/2009 | WO2009008004A3 Sustained release formulations of divalproex sodium |
| 03/05/2009 | WO2009007996A3 Cyclodextrin complexes of atovaquone |
| 03/05/2009 | WO2008151775A3 Hyperbranched polymers based on cyclodextrins and poly(amidoamines) for the controlled release of insoluble drugs |
| 03/05/2009 | WO2008151257A3 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 03/05/2009 | WO2008134761A3 Modification of biological targeting groups for the treatment of cancer |
| 03/05/2009 | WO2008129106A3 Nanoparticles comprising a cyclodextrin and a biologically active molecule and uses thereof |
| 03/05/2009 | WO2008035371A4 Dietary anti-bacterial compositions |
| 03/05/2009 | WO2007132205A3 Nanoparticle pharmaceutical carrier |
| 03/05/2009 | US20090062406 Aqueous concentrates of isethionate, taurate and betaine |
| 03/05/2009 | US20090062405 Cyclopropanecarboxaldehydes and their use in perfume compositions |
| 03/05/2009 | US20090062404 Pharmaceutical composition |
| 03/05/2009 | US20090062391 Use of a virucidal ointment in the nares for prevention of transmission and contraction of common colds |
| 03/05/2009 | US20090062382 External preparation for improving coital function |
| 03/05/2009 | US20090062362 Veterinary Formulation for Administration of a Water-Insoluble Drug to a Target Animal Through a Water Distribution System |
| 03/05/2009 | US20090062249 An intraocular, biodegradable drug delivery system comprising anecortave acetate and a biodegradable glycolic acid-lactic acid copolymer effective in releasing the immunosuppressant into the eye over a period of > 3 weeks; sustained release from a single pellet or a single extruded filament |
| 03/05/2009 | US20090062236 Programmable genotoxic agents and uses therefor |
| 03/05/2009 | US20090062205 Reconstitution Medium For Protein and Peptide Formulations |
| 03/05/2009 | US20090062201 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 03/05/2009 | US20090060998 Lipid-based dispersions useful for drug delivery |
| 03/05/2009 | US20090060992 Preparation of magneto-vesicles with DOPE/DDAB layers |
| 03/05/2009 | US20090060991 Glutathione based delivery system |
| 03/05/2009 | US20090060990 Nsaid formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 03/05/2009 | US20090060989 Nsaid formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 03/05/2009 | US20090060986 Transdermal delivery systems |
| 03/05/2009 | US20090060981 Contact lens based bioactive agent delivery system |
| 03/05/2009 | US20090060979 Controlled release of biologically active compounds |
| 03/05/2009 | US20090060975 Containment system for delivery of biological products and method of surgery |
| 03/05/2009 | US20090060948 Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
| 03/05/2009 | US20090060945 Integration of meningococcal conjugate vaccination |
| 03/05/2009 | US20090060941 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 03/05/2009 | US20090060929 Gene therapy and vaccination; non-viral transfection complex of a nucleic acid, optionally, a lipid,a polycationic nucleic acid-binding component, and a cell surface receptor binding peptide of given sequence |
| 03/05/2009 | US20090060899 Composition of organic compounds |
| 03/05/2009 | US20090060888 Regulated transcription of targeted genes and other biological events |
| 03/05/2009 | US20090060885 Composition For Treatment of Articular Cartilage Damage |
| 03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
| 03/05/2009 | US20090060864 administering an antitumor agent containing a combination of an alpha v beta 3 angiogenisis antagonist and an anti-tumor immunotherapeutic agent, which is a fusion protein of a cytokine IL-2 and an Ig heavy chain that immunoreacts with a tumor associated antigen target; drug target |
| 03/05/2009 | US20090060840 Lanthanide Nanoparticle Conjugates and Uses Thereof |
| 03/05/2009 | US20090060839 Gold Nanoparticle Conjugates and Uses Thereof |
| 03/05/2009 | DE102007041625A1 Neue Gelatine-Wirkstoff-Konjugate New gelatin-drug conjugates |
| 03/05/2009 | DE102007041028A1 Verwendung estermodifizierter Organopolysiloxane zur Herstellung kosmetischer oder pharmazeutischer Kompositionen Use ester-modified organopolysiloxanes for the preparation of cosmetic or pharmaceutical compositions |
| 03/05/2009 | DE102007040932A1 Liquid granulocyte colony-stimulating factor formulation, e.g. for treating cancer, neutropenia, HIV infections or neurological disorders, comprises a sugar alcohol, surfactant and acetate buffer |
| 03/05/2009 | CA2709546A1 Surgical hydrogel |
| 03/05/2009 | CA2697951A1 Amino acid pairing-based self assembling peptides and methods |
| 03/05/2009 | CA2697949A1 Cancer imaging and treatment |
| 03/05/2009 | CA2697943A1 Local topical administration formulations containing fipronil |
| 03/05/2009 | CA2697825A1 Non-aqueous pharmaceutical compositions |
| 03/05/2009 | CA2697729A1 Influenza antigen delivery vectors and constructs |
| 03/05/2009 | CA2697681A1 Selective cytopheresis devices and related methods thereof |
| 03/05/2009 | CA2697529A1 Receptor-targeting reagents |
| 03/05/2009 | CA2697376A1 Liquid formulation of g-csf |
| 03/05/2009 | CA2697361A1 Alpha-synuclein binding diagnostic agent |
| 03/05/2009 | CA2696594A1 Liquid formulation of g-csf conjugate |
| 03/05/2009 | CA2694084A1 Radiopharmaceutical composition |
| 03/04/2009 | EP2030634A1 Medicament for and method of treatment of prostate cancer |
| 03/04/2009 | EP2030614A1 Pharmaceutical Composition comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol and a lecithin |
| 03/04/2009 | EP2030612A1 Pharmaceutical composition for treating burns (variants) and a method for the production thereof (variants) |
| 03/04/2009 | EP2030611A1 Injectable multimodal polymer depot compositions and uses thereof |
| 03/04/2009 | EP2030610A1 Non-aqueous pharmaceutical compositions |
| 03/04/2009 | EP2029748A2 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family and their uses for vaccination and intra-cellular vectorisation |
| 03/04/2009 | EP2029644A1 Poly (vinyl alcohol) polymers, uses and preparation thereof |
| 03/04/2009 | EP2029629A1 Hydrogels of polysaccharide mixtures for tissue engineering and as carriers of active compounds |
| 03/04/2009 | EP2029626A2 Immune-derived moieties reactive against lysophosphatidic acid |